Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 1c

Adaptive Biotechnologies Reports First Quarter 2022 Financial Results

May 4, 2022 4:06 PM EDT

SEATTLE, May 04, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Adaptive Biotechnologies) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended March 31, 2022.

We started the year strong and completed a strategic reorganization of our company around two key business areas: MRD and Immune Medicine, said Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies. I am encouraged by the solid momentum across both business areas as we optimize our resource... More